COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus

NCT00526279 · clinicaltrials.gov ↗
COMPLETED
Status
9000
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca